The Journal of infectious diseases · 2026
Lineage dynamics and risk factors underlying serotype 4 invasive pneumococcal disease in Spain.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pérez-García Covadonga, Llorente Joaquin, Alastuey Maria Elena Aguirre, Llamosí Mirella, Gil-Prieto Ruth, Laghlali Gabriel, El-Ayache Farah, Yan Vivian, Schotsaert Michael, Del Diego-Salas Jorge, Cisneros Jose Miguel, García-Sastre Adolfo, Domenech Mirian, Sempere Julio, Yuste Jose
Аннотация
BACKGROUND: The emergence of vaccine-covered serotypes causing invasive pneumococcal disease (IPD) is a serious concern worldwide.
METHODS: We characterized all national serotype 4 IPD isolates from children and adults received at the Spanish Pneumococcal Reference Laboratory (2009-24).
RESULTS: We investigated the unexpected rise of serotype 4 causing IPD in young adults after the COVID-19 pandemic, affecting elderly population in recent years. Epidemiological and genomic analysis confirmed that the rise started as an abrupt cluster of cases in Seville (Andalusia) in the year 2022 due to the ST15063 within GPSC12 lineage. This outbreak initially affected non-vaccinated young individuals associated with high rates of tobacco smoking, alcohol, and inhaled drugs followed by a general distribution through the country in the following years that affected adults ≥ 65 years old. Moreover, ST15063 serotype 4 strains displayed enhanced infection rates of human lung cells that significantly increased in the presence of cigarette smoke exposure and by influenza H3N2 coinfection.
CONCLUSIONS: These findings highlight the need for targeted vaccination strategies, molecular surveillance, and focused interventions in high-risk populations.
METHODS: We characterized all national serotype 4 IPD isolates from children and adults received at the Spanish Pneumococcal Reference Laboratory (2009-24).
RESULTS: We investigated the unexpected rise of serotype 4 causing IPD in young adults after the COVID-19 pandemic, affecting elderly population in recent years. Epidemiological and genomic analysis confirmed that the rise started as an abrupt cluster of cases in Seville (Andalusia) in the year 2022 due to the ST15063 within GPSC12 lineage. This outbreak initially affected non-vaccinated young individuals associated with high rates of tobacco smoking, alcohol, and inhaled drugs followed by a general distribution through the country in the following years that affected adults ≥ 65 years old. Moreover, ST15063 serotype 4 strains displayed enhanced infection rates of human lung cells that significantly increased in the presence of cigarette smoke exposure and by influenza H3N2 coinfection.
CONCLUSIONS: These findings highlight the need for targeted vaccination strategies, molecular surveillance, and focused interventions in high-risk populations.